Systemic Sclerosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Systemic Sclerosis (Scleroderma) Clinical Trials Market Report Overview
The Systemic Sclerosis (Scleroderma) clinical trial market research report provides an overview of the Systemic Sclerosis (Scleroderma) Clinical trials scenario. This report provides top-line data relating to the clinical trials on Systemic Sclerosis (Scleroderma) and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. It provides prominent drugs for in-progress trials (based on the number of ongoing trials).
Key Regions | · Europe
· North America · Asia-Pacific · Middle East & Africa · South & Central America |
Key Countries | · The US
· The UK · Italy · France · Japan · Germany · Canada · Russia · China · Spain |
Key Sponsor Types | · Institution
· Company · Government |
Leading Sponsors | · Johnson & Johnson
· Bristol-Myers Squibb Co · C. H. Boehringer Sohn AG & Co KG · F. Hoffmann-La Roche Ltd · Sanofi · GSK plc · Novartis AG · Horizon Therapeutics Plc · Rho Inc · Thermo Fisher Scientific Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Scleroderma Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Scleroderma clinical trials market are Europe, North America, Asia-Pacific, the Middle East & Africa, and South & Central America. Europe dominates the market as of July 2023.
In a country-wise analysis, as of July 2023, the US has the highest number of Scleroderma clinical trials, followed by the UK, Italy, France, Japan, Germany, Canada, Russia, China, and Spain.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Italy has the highest proportion of Systemic Sclerosis (Scleroderma) to Immunology clinical trials as of July 2023. Moreover, most of the clinical trials were conducted in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia has the highest proportion of Systemic Sclerosis (Scleroderma) to Immunology clinical trials as of July 2023. Furthermore, out of all the clinical trials conducted in the E7 countries, the majority were in Russia.
Scleroderma Clinical Trials Analysis by Regions, 2023 (%)
Buy Full Report for More Regional Insights into Scleroderma Clinical Trials Market
Scleroderma Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Scleroderma clinical trials market are institution, company, and the government. Out of them, the institution sponsor type dominates the market.
Scleroderma Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
Buy Full Report for More Sponsor Type Insights into Scleroderma Clinical Trials Market
Scleroderma Clinical Trials Market - Competitive Landscape
The leading sponsors in the Scleroderma clinical trials market are Johnson & Johnson, Bristol-Myers Squibb Co, C. H. Boehringer Sohn AG & Co KG, F. Hoffmann-La Roche Ltd, Sanofi, GSK plc, Novartis AG, Horizon Therapeutics Plc, Rho Inc, and Thermo Fisher Scientific Inc. Johnson & Johnson led the Scleroderma clinical trials market in July 2023.
Scleroderma Clinical Trials Market Analysis by Sponsors, 2023 (%)
Buy Full Report to Know More About the Leading Sponsors in Scleroderma Clinical Trials Market
Segments Covered in the Report
Scleroderma Clinical Trials Regional Outlook (2023)
- Europe
- North America
- Asia-Pacific
- Middle East & Africa
- South & Central America
Scleroderma Clinical Trials Country Outlook (2023)
- The US
- The UK
- Italy
- France
- Japan
- Germany
- Canada
- Russia
- China
- Spain
Scleroderma Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) about them
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regard to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Bristol-Myers Squibb Co
C. H. Boehringer Sohn AG & Co KG
F. Hoffmann-La Roche Ltd
Sanofi
GSK plc
Novartis AG
Horizon Therapeutics Plc
Rho Inc
Thermo Fisher Scientific Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which is the leading region in the Scleroderma clinical trials market?
Europe is the leading region in the Scleroderma clinical trials market as of July 2023.
-
Which is the leading country in the Scleroderma clinical trials market?
The US is the leading country in the Scleroderma clinical trials market as of July 2023.
-
Which is the leading sponsor type in the Scleroderma clinical trials market?
Institution is the leading sponsor type in the Scleroderma clinical trials market as of July 2023.
-
Who are the leading sponsors in the Scleroderma clinical trials market?
The leading sponsors in the Scleroderma clinical trials market are Johnson & Johnson, Bristol-Myers Squibb Co, C. H. Boehringer Sohn AG & Co KG, F. Hoffmann-La Roche Ltd, Sanofi, GSK plc, Novartis AG, Horizon Therapeutics Plc, Rho Inc, and Thermo Fisher Scientific Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.